Abstract
We describe the case of a 63-year-old man who is reported to have the first confirmed case of COVID-19 reinfection in Campania Region, Italy. We found that the two episodes were caused by virus strains with clearly different genome sequences. The patient, a retired nurse, had a very low level of antibodies IgG directed against the spike protein 14 days after his first Pfizer/BioNTek vaccine shot.
Keywords: COVID-19; adult intensive care; immunological products and vaccines; pneumonia (infectious disease).
All Keywords
【저자키워드】 COVID-19, immunological products and vaccines, adult intensive care, pneumonia (infectious disease), 【초록키워드】 IgG, Vaccine, Pneumonia, antibody, Infectious disease, Italy, Reinfection, Region, Patient, Intensive, Genome sequences, Campania, virus strain, immunological, caused, reported, the spike protein, 【제목키워드】 Reinfection,
【저자키워드】 COVID-19, immunological products and vaccines, adult intensive care, pneumonia (infectious disease), 【초록키워드】 IgG, Vaccine, Pneumonia, antibody, Infectious disease, Italy, Reinfection, Region, Patient, Intensive, Genome sequences, Campania, virus strain, immunological, caused, reported, the spike protein, 【제목키워드】 Reinfection,
{{{ 추상적인 }}}
이탈리아 캄파니아 지역에서 처음으로 확인된 COVID-19 재감염 사례가 보고된 63세 남성의 사례를 설명합니다. 우리는 두 가지 에피소드가 분명히 다른 게놈 서열을 가진 바이러스 변종에 의해 발생했음을 발견했습니다. 은퇴한 간호사인 환자는 첫 번째 Pfizer/BioNTek 백신 접종 후 14일째에 스파이크 단백질에 대한 항체 IgG 수치가 매우 낮았습니다.
{{ 키워드: }} 코로나19; 성인 집중 치료; 면역학적 제품 및 백신; 폐렴(전염병).